Beatriz Villarejo-Zori

Beatriz Villarejo-Zori

Auto-generated profile, based on publicly available information

Beatriz Villarejo-Zori

Department of Cellular and Molecular Biology, Centro de Investigaciones Biológicas Margarita Salas, CSIC, Madrid, Spain

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2022 in The EMBO Journal
Verified
Journal Article
Open access
LWLéa P Wilhelm
Léa P Wilhelm
JZJuan Zapata‐Muñoz
Juan Zapata‐Muñoz
BVBeatriz Villarejo‐Zori
Beatriz Villarejo‐Zori
SPStephanie Pellegrin
Stephanie Pellegrin
CFCatarina Martins Freire
Catarina Martins Freire
Ian GanleyIan Ganley
Ian Ganley
Mitochondria and peroxisomes are closely related metabolic organelles, both in terms of origin and in terms of function. Mitochondria and peroxisomes can also be turned over by autophagy, in processes termed mitophagy and pexophagy, respectively. However, despite their close relationship, it is not known if both organelles are turned over under similar conditions, and if so, how this might be coordinated molecularly. Here, we find that multiple selective autophagy pathways are activated upon iron chelation and show that mitophagy and pexophagy occur in a BNIP3L/NIX‐dependent manner. We reveal that the outer mitochondrial membrane‐anchored NIX protein, previously described as a mitophagy receptor, also independently localises to peroxisomes and drives pexophagy. We show this process happens in vivo, with mouse tissue that lacks NIX having a higher peroxisomal content. We further show that pexophagy is stimulated under the same physiological conditions that activate mitophagy, including cardiomyocyte and erythrocyte differentiation. Taken together, our work uncovers a dual role for NIX, not only in mitophagy but also in pexophagy, thus illustrating the interconnection between selective autophagy pathways.

16 April 2018 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
ASAlonso Sánchez-Cruz
Alonso Sánchez-Cruz
BVBeatriz Villarejo-Zori
Beatriz Villarejo-Zori
MMMiguel Marchena
Miguel Marchena
JZJosefa Zaldivar-Díez
Josefa Zaldivar-Díez
VPValle Palomo
Valle Palomo
CCCATALINA HERNÁNDEZ/ CIB-Margarita CSIC
CATALINA HERNÁNDEZ/ CIB-Margarita CSIC
Retinitis pigmentosa (RP) is a group of hereditary retinal neurodegenerative conditions characterized by primary dysfunction and death of photoreceptor cells, resulting in visual loss and, eventually, blindness. To date, no effective therapies have been transferred to clinic. Given the diverse genetic etiology of RP, targeting common cellular and molecular retinal alterations has emerged as a potential therapeutic strategy. Using the Pde6b rd10/rd10 mouse model of RP, we investigated the effects of daily intraperitoneal administration of VP3.15, a small-molecule heterocyclic GSK-3 inhibitor. Gene expression was analyzed by quantitative PCR and protein expression and phosphorylation by Western blot. Photoreceptor preservation was evaluated by histological analysis and visual function was assessed by electroretinography. In rd10 retinas, increased expression of pro-inflammatory markers and reactive gliosis coincided with the early stages of retinal degeneration. Compared with wild-type controls, GSK-3β expression (mRNA and protein) remained unchanged during the retinal degeneration period. However, levels of GSK-3βSer9 and its regulator AktSer473 were increased in rd10 versus wild-type retinas. In vivo administration of VP3.15 reduced photoreceptor cell loss and preserved visual function. This neuroprotective effect was accompanied by a decrease in the expression of neuroinflammatory markers. These results provide proof of concept of the therapeutic potential of VP3.15 for the treatment of retinal neurodegenerative conditions in general, and RP in particular.

15 November 2022 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
CFCláudia Figueiredo-Pereira
Cláudia Figueiredo-Pereira
BVBeatriz Villarejo-Zori
Beatriz Villarejo-Zori
PCPedro C. Cipriano
Pedro C. Cipriano
DTDiana Tavares
Diana Tavares
IRIgnacio Ramírez-Pardo
Ignacio Ramírez-Pardo
Helena L.A. VieiraHelena L.A. Vieira
Helena L.A. Vieira

Verified
Journal Article
Open access
PDF file
IRInes Rosignol
Ines Rosignol
BVBeatriz Villarejo-Zori
Beatriz Villarejo-Zori
PTPetra Teresak
Petra Teresak
ESElena Sierra-Filardi
Elena Sierra-Filardi
Xandra PereiroXandra Pereiro
Xandra Pereiro
Patricia BoyaPatricia Boya
Patricia Boya
Mitochondrial damage plays a prominent role in glaucoma. The only way cells can degrade whole mitochondria is via autophagy, in a process called mitophagy. Thus, studying mitophagy in the context of glaucoma is essential to understand the disease. Up to date limited tools are available for analyzing mitophagy in vivo. We have taken advantage of the mito-QC reporter, a recently generated mouse model that allows an accurate mitophagy assessment to fill this gap. We used primary RGCs and retinal explants derived from mito-QC mice to quantify mitophagy activation in vitro and ex vivo. We also analyzed mitophagy in retinal ganglion cells (RGCs), in vivo, using different mitophagy inducers, as well as after optic nerve crush (ONC) in mice, a commonly used surgical procedure to model glaucoma. Using mito-QC reporter we quantified mitophagy induced by several known inducers in primary RGCs in vitro, ex vivo and in vivo. We also found that RGCs were rescued from some glaucoma relevant stress factors by incubation with the iron chelator deferiprone (DFP). Thus, the mito-QC reporter-based model is a valuable tool for accurately analyzing mitophagy in the context of glaucoma.

24 July 2022 in Autophagy
Verified
Journal Article
Open access
IRIgnacio Ramírez-Pardo
Ignacio Ramírez-Pardo
BVBeatriz Villarejo-Zori
Beatriz Villarejo-Zori
JJJuan Ignacio Jiménez-Loygorri
Juan Ignacio Jiménez-Loygorri
ESElena Sierra-Filardi
Elena Sierra-Filardi
SASandra Alonso-Gil
Sandra Alonso-Gil
Patricia BoyaPatricia Boya
Patricia Boya
Macroautophagy/autophagy is a key process in the maintenance of cellular homeostasis. The age-dependent decline in retinal autophagy has been associated with photoreceptor degeneration. Retinal dysfunction can also result from damage to the retinal pigment epithelium (RPE), as the RPE-retina constitutes an important metabolic ecosystem that must be finely tuned to preserve visual function. While studies of mice lacking essential autophagy genes have revealed a predisposition to retinal degeneration, the consequences of a moderate reduction in autophagy, similar to that which occurs during physiological aging, remain unclear. Here, we described a retinal phenotype consistent with accelerated aging in mice carrying a haploinsufficiency for Ambra1, a pro-autophagic gene. These mice showed protein aggregation in the retina and RPE, metabolic underperformance, and premature vision loss. Moreover, Ambra1+/gt mice were more prone to retinal degeneration after RPE stress. These findings indicate that autophagy provides crucial support to RPE-retinal metabolism and protects the retina against stress and physiological aging. Abbreviations : 4-HNE: 4-hydroxynonenal; AMBRA1: autophagy and beclin 1 regulator 1, AMD: age-related macular degeneration;; GCL: ganglion cell layer; GFAP: glial fibrillary acidic protein; GLUL: glutamine synthetase/glutamate-ammonia ligase; HCL: hierarchical clustering; INL: inner nuclear layer; IPL: inner plexiform layer; LC/GC-MS: liquid chromatography/gas chromatography–mass spectrometry; MA: middle-aged; MTDR: MitoTracker Deep Red; MFI: mean fluorescence intensity; NL: NH4Cl and leupeptin; Nqo: NAD(P)H quinone dehydrogenase; ONL: outer nuclear layer; OPL: outer plexiform layer; OP: oscillatory potentials; OXPHOS: oxidative phosphorylation; PCR: polymerase chain reaction; PRKC/PKCα: protein kinase C; POS: photoreceptor outer segment; RGC: retinal ganglion cells; RPE: retinal pigment epithelium; SI: sodium iodate; TCA: tricarboxylic acid.

22 October 2017 in Cells
Verified
Journal Article
Open access
PDF file
RGRaquel Gomez-Sintes
Raquel Gomez-Sintes
BVBeatriz Villarejo-Zori
Beatriz Villarejo-Zori
ASAna Serrano-Puebla
Ana Serrano-Puebla
LELorena Esteban-Martínez
Lorena Esteban-Martínez
ESElena Sierra-Filardi
Elena Sierra-Filardi
Patricia BoyaPatricia Boya
Patricia Boya
Autophagy is a catabolic pathway that mediates the degradation and recycling of intracellular components, and is a key player in a variety of physiological processes in cells and tissues. Recent studies of autophagy in the eye suggest that this pathway is fundamental for the preservation of retinal homeostasis. Given its accessible location outside the brain, the retina is an ideal organ in which to study the central nervous system and a wide range of neuronal processes, from development to neurodegeneration. Here we review several methods used to assess autophagy in the retina in both physiological and pathological conditions.